Cargando…
Adherence, virological outcome, and drug resistance in Chinese HIV patients receiving first-line antiretroviral therapy from 2011 to 2015
Stavudine (D4T), zidovudine (AZT), and tenofovir (TDF) along with lamivudine (3TC) are the most widely used HIV treatment regimens in China. China's National Free Antiretroviral Treatment Programme (NFATP) has replaced D4T with AZT or TDF in the standard first-line regimens since 2010. Few stud...
Autores principales: | Liu, Pengtao, Liao, Lingjie, Xu, Wei, Yan, Jing, Zuo, Zhongbao, Leng, Xuebing, Wang, Jing, Kan, Wei, You, Yinghui, Xing, Hui, Ruan, Yuhua, Shao, Yiming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320000/ https://www.ncbi.nlm.nih.gov/pubmed/30558015 http://dx.doi.org/10.1097/MD.0000000000013555 |
Ejemplares similares
-
Drug Resistance and Virological Failure among HIV-Infected Patients after a Decade of Antiretroviral Treatment Expansion in Eight Provinces of China
por: Zuo, Zhongbao, et al.
Publicado: (2016) -
HIV drug resistance in patients in China’s national HIV treatment programme who have been on first-line ART for at least 9 months
por: Liu, Pengtao, et al.
Publicado: (2020) -
Low Virologic Failure and Drug Resistance among HIV-Infected Patients Receiving Hospital-Based ART While Care and Outreach through Community in Guangxi, China
por: Liang, Shujia, et al.
Publicado: (2015) -
HIV virological failure and drug resistance among injecting drug users receiving first-line ART in China
por: Leng, Xuebing, et al.
Publicado: (2014) -
Predictors of HIV virological failure and drug resistance in Chinese patients after 48 months of antiretroviral treatment, 2008–2012: a prospective cohort study
por: Kan, Wei, et al.
Publicado: (2017)